Watts, C.; Ashkan, K.; Jenkinson, M.D.; Price, S.J.; Santarius, T.; Matys, T.; Zhang, T.T.; Finch, A.; Collins, P.; Allinson, K.;
et al. An Evaluation of the Tolerability and Feasibility of Combining 5-Amino-Levulinic Acid (5-ALA) with BCNU Wafers in the Surgical Management of Primary Glioblastoma. Cancers 2021, 13, 3241.
https://doi.org/10.3390/cancers13133241
AMA Style
Watts C, Ashkan K, Jenkinson MD, Price SJ, Santarius T, Matys T, Zhang TT, Finch A, Collins P, Allinson K,
et al. An Evaluation of the Tolerability and Feasibility of Combining 5-Amino-Levulinic Acid (5-ALA) with BCNU Wafers in the Surgical Management of Primary Glioblastoma. Cancers. 2021; 13(13):3241.
https://doi.org/10.3390/cancers13133241
Chicago/Turabian Style
Watts, Colin, Keyoumars Ashkan, Michael D. Jenkinson, Stephen J. Price, Thomas Santarius, Tomasz Matys, Ting Ting Zhang, Alina Finch, Peter Collins, Kieren Allinson,
and et al. 2021. "An Evaluation of the Tolerability and Feasibility of Combining 5-Amino-Levulinic Acid (5-ALA) with BCNU Wafers in the Surgical Management of Primary Glioblastoma" Cancers 13, no. 13: 3241.
https://doi.org/10.3390/cancers13133241
APA Style
Watts, C., Ashkan, K., Jenkinson, M. D., Price, S. J., Santarius, T., Matys, T., Zhang, T. T., Finch, A., Collins, P., Allinson, K., Jefferies, S. J., Scoffings, D. J., Zisakis, A., Phillips, M., Wanek, K., Smith, P., Clifton-Hadley, L., & Counsell, N.
(2021). An Evaluation of the Tolerability and Feasibility of Combining 5-Amino-Levulinic Acid (5-ALA) with BCNU Wafers in the Surgical Management of Primary Glioblastoma. Cancers, 13(13), 3241.
https://doi.org/10.3390/cancers13133241
